Search

Your search keyword '"Asakura H"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Asakura H" Remove constraint Author: "Asakura H" Topic anticoagulants Remove constraint Topic: anticoagulants
22 results on '"Asakura H"'

Search Results

1. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.

2. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.

3. Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities.

4. Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban.

5. [An antithrombotic therapy from the viewpoint of hematology].

6. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report.

7. [Pathophysiology and classification of thrombosis].

8. [Diagnosis and treatment of disseminated intravascular coagulation].

9. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.

10. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.

11. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.

12. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.

13. [Hyperhomocysteinemia: development of deep vein thrombosis in another location during heparin anticoagulation therapy].

14. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].

15. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.

16. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.

17. [Treatment of disseminated intravascular coagulation].

18. Edoxaban versus warfarin in patients with atrial fibrillation

19. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

20. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

21. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

22. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

Catalog

Books, media, physical & digital resources